On July 13, Vectans Pharma participated to the Commemorative Lecture for new release of ORAVI®/LORAMYC® Mucoadhesive Tablet 50mg, a meeting organized by our Japanese partners, Sosei Heptares and FujiFilm Pharma. The meeting hosted more than 200 Japanese specialists in Oropharyngeal Candidiasis, coming from whole over Japan.

Our CMO, Dr Stefan Lempereur, gave a lecture entitled “The ORAVI® story, from discovery to clinics”. The Academic session was followed by an information exchange meeting with all attendees, allowing the CEOs of the three companies involved to make speeches, and allowing interesting discussions with the local experts.